Literature DB >> 13013156

Experiences with aspirin (Acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis.

L L CRAVEN.   

Abstract

Entities:  

Keywords:  ACETYLSALICYLIC ACID/therapeutic use; CORONARY DISEASE; THROMBOSIS

Mesh:

Substances:

Year:  1953        PMID: 13013156

Source DB:  PubMed          Journal:  Miss Valley Med J        ISSN: 0096-5480


× No keyword cloud information.
  24 in total

1.  The Emergence of Thrombocardiology.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1994       Impact factor: 2.300

Review 2.  Adventures in vascular biology: a tale of two mediators.

Authors:  S Moncada
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-05-29       Impact factor: 6.237

3.  AspirinWorks: a new immunologic diagnostic test for monitoring aspirin effect.

Authors:  F Jon Geske; Kirk E Guyer; Gordon Ens
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

4.  The early clinical history of salicylates in rheumatology and pain.

Authors:  T Hedner; B Everts
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

5.  Aspirin for reducing cancer metastases?

Authors:  U K Henschke; G J Luande; J D Choppala
Journal:  J Natl Med Assoc       Date:  1977-08       Impact factor: 1.798

Review 6.  Current developments in anti-platelet therapy.

Authors:  Florian B Mayr; Bernd Jilma
Journal:  Wien Med Wochenschr       Date:  2006-09

Review 7.  The Second Gaddum Lecture: its origins and outcomes.

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  2020-02-05       Impact factor: 8.739

8.  An intervention study-the aspirin myocardial infarction study.

Authors: 
Journal:  Lipids       Date:  1977-01       Impact factor: 1.880

Review 9.  Aspirin dosing in cardiovascular disease prevention and management: an update.

Authors:  Leila Ganjehei; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

10.  Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.

Authors:  Desmond J Fitzgerald; Garret A Fitzgerald
Journal:  Circ Res       Date:  2013-01-04       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.